| Date | Research Firm | Action | Current | PT |
|---|---|---|---|---|
| 12/07/20 | Litchfield Hills | Initiates Coverage On | Buy | 3.0 |
| 8/17/18 | H.C. Wainwright | Downgrades | Neutral | |
| 5/16/17 | Maxim Group | Downgrades | Hold | |
| 4/20/17 | Roth Capital | Initiates Coverage On | Buy | 2.0 |
| 3/13/17 | Rodman & Renshaw | Assumes | Buy | 2.0 |
| 1/27/17 | Maxim Group | Initiates Coverage On | Buy | 2.0 |
| 8/22/16 | Rodman & Renshaw | Initiates Coverage on | Buy | 2.0 |
Mateon Therapeutics analyst ratings
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated